Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1470266
This article is part of the Research Topic Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics. View all 5 articles

Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics

Provisionally accepted
Yvan Torrente Yvan Torrente 1,2,3*Chiara Villa Chiara Villa 1,2Andrea Farini Andrea Farini 3
  • 1 Dino Ferrari Center, University of Milan, Milan, Lombardy, Italy
  • 2 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy, Milano, Lombardy, Italy
  • 3 IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital, Milan, Lombardy, Italy

The final, formatted version of the article will be published soon.

    Keywords: miRNA, DMD, Muscular Dystrophies, Inflammation, GHS (growth hormone secretagogues), NLRP3

    Received: 25 Jul 2024; Accepted: 12 Aug 2024.

    Copyright: © 2024 Torrente, Villa and Farini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yvan Torrente, Dino Ferrari Center, University of Milan, Milan, 20122, Lombardy, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.